MediWound Ltd. - Ordinary Shares (MDWD)
MDWD moved a median of +0.03% 30 minutes after news, and -0.16% by the close. How MDWD actually reacts to news — the realized, point-in-time move the market made, measured across 168 labeled events over the last three years with zero look-ahead.
MDWD’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 153 |
| 30-min | +0.03% | 51% | 163 |
| 60-min | +0.35% | 57% | 163 |
| to close | -0.16% | 48% | 165 |
| Middle 50% of MDWD reactions | -0.83% to +1.24% |
|---|---|
| Median reaction (30-min) | +0.03% |
| Measured reactions | 168 |
Half of all MediWound Ltd. - Ordinary Shares news events land between -0.83% and +1.24% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MDWD reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 13 | +0.23% | 54% | -0.43% |
| Rating reiterations | 27 | +0.07% | 52% | -0.19% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how MDWD ranks against every other measured name →
That’s how MDWD usually reacts — get an email when it moves on news →Email me when MDWD moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MDWD's baseline. Nothing else.
Recent MDWD events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | -0.04% | +2.75% | |
| Form 6-K MediWound Ltd. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +1.83% | -3.77% | |
| MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +1.83% | -3.77% | |
| MediWound to Report Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.96% | -1.71% | |
| Form 6-K MediWound Ltd. For: May 27 | SEC filing · Form 6-K | SEC EDGAR | -0.32% | -9.30% | |
| MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | -0.32% | -9.30% | |
| MediWound to Report First Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.00% | +0.17% | |
| Form 6-K MediWound Ltd. For: May 06 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.17% | |
| Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement | Press release | GlobeNewswire | +0.00% | -0.11% | |
| MediWound to Present New EscharEx® Data at Leading Wound Care Conferences | Press release | GlobeNewswire | — | +2.97% | |
| Form 6-K MediWound Ltd. For: Apr 02 | SEC filing · Form 6-K | SEC EDGAR | -0.34% | -5.92% | |
| MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million | Press release | GlobeNewswire | +1.26% | +0.60% | |
| Form 6-K MediWound Ltd. For: Mar 30 | SEC filing · Form 6-K | SEC EDGAR | +0.70% | +2.74% | |
| Form 20-F MediWound Ltd. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +0.00% | +1.28% | |
| Form 6-K MediWound Ltd. For: Mar 05 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +1.28% | |
| Form S-8 MediWound Ltd. | SEC filing · Form S-8 | SEC EDGAR | +0.23% | -0.87% | |
| MediWound Files Annual Report on Form 20-F | Press release | GlobeNewswire | +0.23% | -0.87% | |
| MediWound Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.00% | +1.28% | |
| Form 6-K MediWound Ltd. For: Feb 19 | SEC filing · Form 6-K | SEC EDGAR | -0.81% | +3.29% | |
| MediWound to Report Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.00% | +1.53% | |
| MediWound to Present at Upcoming Investor Conferences | Press release | GlobeNewswire | -0.20% | +1.66% | |
| Form 6-K MediWound Ltd. For: Jan 15 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -5.69% | |
| Form 6-K MediWound Ltd. For: Jan 12 | SEC filing · Form 6-K | SEC EDGAR | -1.59% | -8.84% | |
| MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | -1.59% | -8.84% | |
| MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries | Press release | GlobeNewswire | +0.16% | +1.05% | |
| Form 6-K MediWound Ltd. For: Nov 20 | SEC filing · Form 6-K | SEC EDGAR | +0.63% | -3.66% | |
| MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +0.63% | -3.66% | |
| MediWound to Report Third Quarter 2025 Financial Results | Press release | GlobeNewswire | — | +1.06% | |
| MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® | Press release | GlobeNewswire | -0.44% | +0.27% | |
| Form 6-K MediWound Ltd. For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -2.62% | |
| Form 6-K MediWound Ltd. For: Sep 29 | SEC filing · Form 6-K | SEC EDGAR | +1.06% | +1.18% | |
| MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares | Press release | GlobeNewswire | +1.06% | +1.18% | |
| MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia | Press release | GlobeNewswire | +0.00% | -3.44% | |
| MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress | Press release | GlobeNewswire | +0.97% | +0.36% | |
| MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference | Press release | GlobeNewswire | +0.23% | +0.58% | |
| Form 6-K MediWound Ltd. For: Aug 19 | SEC filing · Form 6-K | SEC EDGAR | +0.36% | — | |
| Form 6-K MediWound Ltd. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +1.29% | -0.16% | |
| MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +1.29% | -0.16% | |
| MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers | Press release | GlobeNewswire | -0.05% | -0.85% | |
| MediWound to Report Second Quarter 2025 Financial Results | Press release | GlobeNewswire | -0.43% | -2.08% | |
| Form 6-K MediWound Ltd. For: May 21 | SEC filing · Form 6-K | SEC EDGAR | +1.80% | -2.02% | |
| MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +1.80% | -2.02% | |
| Form 6-K MediWound Ltd. For: May 15 | SEC filing · Form 6-K | SEC EDGAR | +0.30% | +2.45% | |
| MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers | Press release | GlobeNewswire | +3.23% | +5.51% | |
| MediWound to Report First Quarter 2025 Financial Results | Press release | GlobeNewswire | +0.29% | +3.08% | |
| MediWound to Present New EscharEx® Data at Leading Wound Care Conferences | Press release | GlobeNewswire | +0.39% | +0.60% | |
| Form 6-K MediWound Ltd. For: Apr 07 | SEC filing · Form 6-K | SEC EDGAR | -0.57% | -2.48% | |
| Form EFFECT MediWound Ltd. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -5.29% | |
| Form 20-F MediWound Ltd. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +1.27% | -3.54% | |
| Form 6-K MediWound Ltd. For: Mar 19 | SEC filing · Form 6-K | SEC EDGAR | +1.27% | -3.54% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MDWD section they belong to.
Where else MDWD is measured.
MDWD earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BODY AND MIND INC (BMMJ) | 168 | 0.00% | 31% |
| Iterum Therapeutics plc - Ordinary Share (ITRM) | 168 | 0.00% | 49% |
| NanoVibronix, Inc. (NAOV) | 168 | -0.66% | 39% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 168 | -0.37% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is MediWound Ltd. - Ordinary Shares's median reaction calculated?
Every labeled MDWD news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 168 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of MDWD's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does MDWD's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.